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The main objective of this work is to study the liposomal uptake of silver and old nanoparticles. 
Liposomes were prepared in Heating Method. The phospholipids used to prepare liposomes are 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (16:0 PC); 1,2-dipalmitoyl-sn-glycero-3-phospho-
(1'-rac-glycerol) (16:0 PG); 1,2-distearoyl-sn-glycero-3-phosphocholine (18:0 PC); 1,2-
distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (18:0 PG).Four different 
combinations of phospholipids were used to prepare liposomes. In all four combinations two 
types of phospholipids were used. The liposomes were incubated for 30 minute, 1 hour, 2 hour 
and 4 hour with silver and gold nanoparticles in streptavidin coated glass slide. All four 
liposomal formulations had a biotinylated lipid (1-oleoyl-2-[12-biotinyl(aminododecanoyl)]-sn-
glycero-3-phosphocholine) which has a string binding affinity for streptavidin . As a result 
biotinylated liposomes were attached to the streptavidin coated glass slide. After incubation the 
slides were gently washed with water to get rid of unattached nanoparticles and liposomes. Then 
the slides were examined under microscope to study the uptake. Uptake was calculated as 
percentage of liposomes showing nanoparticles attached to them out of total number of 
liposomes. Liposomes prepared from 16PC & 16PG showed highest amount of uptake while 
18PC & 18PG liposomes had lowest uptake for both type of nanoparticles. The uptake was 
slightly higher for the silver nanoparticles for all four types of liposomes than that of gold 
nanoparticles. Concentration of the silver nanoparticles was almost 25 times higher than the gold 
nanoparticle concentration. This suggests that the effect of nanoparticle concentration on the 




At the beginning the uptake rate was higher which decreased over time. Liposomes prepared 



















Liposomes are artificially prepared vesicles composed of a lipid bilayer. Liposomes were 
first made in England in 1961 by Alec D. Bangham [1, 2]. Amphiphillic phospholipid molecule 
in aqueous media can arrange themselves to make a spherical vesicular structure which is called 
Liposome. Phospholipid molecules have both hydrophilic and hydrophobic sections within 
themselves. As a result they can absorb and release two materials with different solubility 
simultaneously [1]. There are various types of liposomes such as unilamellar, multilamellar and 
multi vesicular. Their size ranges from twenty nanometers to few micrometers [1]. 
1.2 Composition of liposomes 
 Liposomes are mainly prepared from different types of phospholipids or combination of 
phospholipids. Cholesterol is used to improve membrane property. Poly ethylene glycol (PEG) 
improves the circulation properties such as longer circulating time [1, 2] 
1.3 Preparation Methods  
 Several methods have been developed by the researchers for the preparation of 
Liposomes. All of them have their own advantages and disadvantages [1- 3]. They are discussed 
in brief below. 
1.3.1 Bangham Method 
 Bangham was the first person to prepare liposomes. His method of preparation is known 




constituent lipids are dissolved in an organic solvent and taken on a round bottom flux. Next step 
is the removal of solvent from the solution usually via evaporation to make a thin dry lipid film 
at the bottom of the flux. The evaporation can be done under nitrogen stream to create an inert 
atmosphere and to prevent oxidation of phospholipids. Then the thin lipid film is hydrated by 
adding some aqueous media along with vortexing to prepare multi lamellar vesicles [1-3]. The 
MLV suspension can be sonicated to prepare large unilamellar vesicles [4].  The hydration and 
sonication steps are carried out above the phase transition temperature of the phospholipids used 
in the preparation [1-4]. 
MLV can be prepared easily in this method. The liposomes produced are heterogeneous 
in size distribution. Encapsulation efficiency is low. Organic solvent cannot be removed fully. 
Sterilization of liposomes is another issue to consider [1-3]. 
1.3.2 Detergent Depletion Method 
Lipid can be hydrated with detergent solution to produce detergent-lipid micelles. Also 
both lipid and detergent can be dried from an organic solution and then the hydration can be 
done to make detergent-lipid micelles. Next step is the removal of detergents to produce 
liposomes. The detergent is removed by dilution, dialysis, and adsorption or column 
chromatography. Among the methods dilution is the simplest.  The liposome produced in this 
method is homogeneous in nature. The rate of detergent removal from the solution and initial 
ratio of detergent to phospholipids determines the size and homogeneity of the liposomes 




The concentration of liposomes at final stage is low. Encapsulation of any hydrophobic 
compound is also low. The method requires much time to produce liposomes. Also some 
hydrophilic compounds may be removed during the detergent removal step [1, 2]. 
1.3.3 Injection Method 
In ether injection method first the constituent lipids are dissolved in ether and the solution 
in injected into an aqueous media which is kept at a temperature higher than the boiling 
temperature of ether. The ether evaporates upon contact with the aqueous media as the 
temperature is high and the lipids form mainly unilamellar liposomes. Millipore filtration can 
remove multilamellar vesicles and aggregates and gel filtration can remove the residual ether 
from the liposomal suspension [5]. 
The process is fast and takes less than an hour. Entrapment efficiency is higher compared 
to that of sonicated liposomes. But the liposomes are heterogeneous in size distribution. Some 
lipids are lost in the filtration process. Aggregation is a problem for uncharged liposomes. 
Compounds which are sensitive to ether are not suitable to be encapsulated in this method [5].   
In ethanol injection method lipids are first dissolved in ethanol and the solution is then 
injected on an aqueous phase to prepare liposomes. The method is simple, first and reproducible. 
Some lipids have low solubility in ethanol and the liposomes are heterogeneous if mixing of the 
phospholipid is not adequate [1, 2]. 
In a variation of the ethanol injection method inkjet printer were used to inject a 
phospholipid solution in ethanol into water to produce unilamellar liposomes in the size range of 




1.3.4 Reverse Phase Evaporation Method 
 In this method first the phospholipids are dissolved in an organic solvent. Then an 
aqueous phase is introduced into the solution. Next step is the removal of organic solvent by 
evaporation under reduced pressure to prepare liposomes. Chromatography, dialysis or 
centrifugation can be used to remove unencapsulated compound and residual organic solvent 
after the preparation. The method is simple and encapsulation efficiency is high.  [7]. 
The method is time consuming. Another disadvantage of the method is the contact of 
organic solvent with the compound to be encapsulated and so the method is not suitable for 
encapsulating some fragile compounds [1, 2, 7]. 
1.3.5 Microfluidic Channel Method 
 In this method a lipid stream dissolved in alcohol is passed in between two aqueous 
streams in a microfluidic channel. Laminar flow condition is maintained in the channel which 
enables controlled diffusive mixing at the two liquid interface and liposomes are produced as a 
result. The size of the liposomes is a function of the ratio of the alcohol to aqueous phase volume 
flow rate. Liposomes of mean diameter from 50 to 150 nm were prepared by adjusting the ration 
of the alcohol to aqueous volumetric flow rate. The method can produce liposomes in 
reproducible manner [8].   
1.3.6 Supercritical Reverse Phase Evaporation Method 
 First phospholipids and organic solvent are taken into a variable volume cell. Then CO2 
is introduced into the cell. The temperature is increased above the phase transition temperature of 




solution containing the compound to be encapsulated is injected into the cell by using a pump. 
The cell component is stirred using a magnetic stirrer. Then the CO2  is removed from the cell 
and a uniform liposome suspension is obtained [9, 10]. The entrapment efficiency of this method 
is higher than Bangham method for water soluble compounds. Liposomes prepared from 
unsaturated phospholipids having unsaturated alkyl chain showed higher entrapment efficiency 
than that of liposomes prepared from phospholipids with saturated alkyl chain. Liposomes 
prepared from phospholipids having both saturated and unsaturated alkyl groups showed some 
value in between. The optimal alkyl chain length was C16 and C18. Higher or lower alkyl chain 
length adverse effect on entrapment efficiency or decreased the osmotic response of liposomal 
membrane [9].  
A modified version of the above method is Improved Supercritical Reverse Phase 
Evaporation Method where no organic solvent is used. The phospholipids and aqueous solution 
are taken on a cell. Cell temperature is increased above the phase transition temperature of the 
phospholipids and CO2 is introduced into the cell. Pressure is raised up to 200 bar. Then the cell 
components are stirred for a definite period of time. Then the CO2 is released to produce 
liposomes. In an experiment entrapment efficiency of glucose was higher than that of Bangham 
method. Liposomes prepared in this method were stable after one month of preparation at room 
temperature [11].    
1.3.7 High Pressure Homogenization Method 
 In this method high pressure homogenizer is used to process liposomes prepared from 
other methods. At high pressure the structure of liposomes is disrupted and rearrangement of 




liposomes is a function of both the inlet pressure and the number of processing cycles. The mean 
diameter decreases with increasing inlet pressure and number of cycles. The entrapped volume 
shows a similar pattern to the mean diameter. On the other hand the mean diameter is increased 
with increasing ionic strength of the aqueous medium [12]. 
The method is simple and can be used for bulk production. The drawbacks are 
sterilization issue, required high pressure and non-homogeneous liposomes preparation [1].  
1.3.8 Extrusion Method 
 In this method unilamellar liposomes can be produced by extruding multilamellar 
vesicles through polycarbonate membrane of desired pore size at elevated pressure [13]. 
Homogeneous unilamellar liposomes can be obtained using filters with nominal pore diameter 
ranging from 30 to 400 nm [14]. Freeze-thaw cycles can be applied along with the extrusion. 
Freezing and thawing prior to extrusion significantly increases the unilamellarity and entrapment 
efficiency of the liposomes [13]. The process is suitable for very high lipid concentration up to 
400 mg/ml [14].  Multilamellar vesicles are produced by hydrating dry lipid film in appropriate 
aqueous buffer along with vortexing. The extrusion is done at a temperature above the phase 
transition temperature of the constituent lipids [13, 14]. Liposomes made in extrusion method 
have been used to encapsulate a magnetic resonance contrast agent and an X-ray contrast agent 
iopromide simultaneously. The liposomes were radiopaque and paramagnetic [15].  
The method does not require the use of organic solvents or detergents. High 





1.3.9 Dual Asymmetric Centrifugation 
 This is a special technique to prepare liposomes. In the method regular centrifugation is 
carried out along with a second rotation of the sample around its own vertical axis. This extra 
rotation creates shear forces in the sample and results in efficient homogenization. First highly 
concentrated blend of hydrogenated phosphatidylcholine, cholesterol and NaCl   was centrifuged 
to prepare viscous vesicular phospholipid gel (VGA) which is subsequently diluted to prepare 
liposomes. The factors affecting the liposomal size are centrifugation speed, concentration of 
lipids, and time of homogenization and use of mixing aid like glass beads. The method was 
reproducible under optimum condition and small liposomes in the size of 60±5 nm can be 
produced [16]. Liposomes prepared in dual asymmetric centrifugation method have been used to 
encapsulate siRNA in sterile condition with high entrapment efficiency. The siRNA was intact 
during the centrifugation process. The liposomal formulation was stable for at least 3 months 
[17]. 
The method is simple and rapid with high entrapment efficiency. It is not suitable for 
bulk production [16, 17]. 
1.3.10 Heating Method 
 In this method the lipids are first hydrated at room temperature for about one to two 
hour. Then they are mixed at high temperature (up to 120
ο
C) in the presence of glycerol. The 
resulting suspension is then extruded through polycarbonate filters of desired pore diameter to 
prepare liposomes. The extrusion is done above the phase transition temperature of the 
phospholipids [18-20]. No degradation of the lipids was observed at high temperature. 






. Liposomes prepared in heating method have been used to prepare stable anionic liposome-
plasmid particles [19]. They have also been used to prepare liposomal gene therapy vector. The 
liposomal formulation was stale in long term. It also   and showed high DNA entrapment 
efficiency and high transfection efficiency [20].  
The method is simple and free of any organic solvent. As a result of heating no extra 
sterilization procedure is required [18-20]. 
1.3.11 Special Method 
  Preparation of liposomes has been reported by changing the pH of the aqueous media 
rapidly followed by a period of equilibrium. First the lipids are hydrated in an aqueous buffer 
along with vortexing at a pre-defined temperature. Then the pH of the medium is suddenly 
increased to 11 by using NaOH and then adjusted to pH 7.4 by using HCl. The time period of pH 
adjusting is termed as pH jumping time. Then the solution is left for a fixed amount of time 
termed as period of equilibrium. At this point the heating and stirring is stooped. Then the 
solution is left to cool to room temperature. Then centrifugation was carried out to eliminate 
aggregation and larger sized liposomes. The factors affecting the liposomal size, shape and 
monodispersity are time interval of pH jump, operation temperature, equilibrium time and type 
of the phospholipids used [21].    
1.4 Applications 
 Liposomes have versatile applications due to their unique properties [1]. Some 






 Natural marine lipid extract containing a high polyunsaturated fatty acid ratio have been 
used to prepare liposomes in a condition that mimic that of topical application in terms of 
temperature, calcium and pH. The toxicology file of the liposomes showed a good eye and skin 
tolerance. As a result these liposomes have a high potential for application in cosmetics [22].    
Liposomes made from egg and soya phospholipids have been used to incorporate a 
moisturizing cream and applied to skin to study the effect of liposomes. Comparison was made 
among the moisturizing cream and four liposomal formulations of the cream. Liposomes made 
from egg phospholipids showed better results than liposomes prepared from soya phospholipids 
in terms of skin water content [23]. 
1.4.2 Food Science 
 Encapsulating Nisin Z in liposomes can improve Nisin stability and inhibitory action in 
cheddar cheese. Encapsulation also protects the cheese starter from the adverse effect of Nisin 
during cheese production. Thus encapsulating Nisin Z in liposomes can eliminate the adverse 
effects of using free Nisin in cheddar cheese [24]. 
Incorporation of lipase encapsulated liposomes in cheddar cheese accelerated lipolysis. 
The treated cheese showed higher moisture and lower fat, protein and ash content than the 
control cheese. The treated cheese was less firm but more elastic and cohesive. Addition of 
encapsulated enzyme accelerated the production of free fatty acid [25]. 
Use of liposomes encapsulating enzymes can be used to accelerate cheese ripening. 




ripening. Experimental cheese had higher moisture but lower protein content. Treated cheese was 
less firm but more brittle than control cheese. Proteolysis and texture development of 
experimental cheese were faster than control cheese [26]. 
Encapsulating ferrous glycinate into liposomes improved the stability of the compound in 
strong acid environment simulating gastrointestinal juice. Thus ferrous glycinate liposomes have 
high potential as iron fortifier [27].      
Ferrous sulphate has been incorporated in liposomes and added to milk to increase the 
iron concentration. The formulation was stable upon heating at 100
ο
C for 30 minute and storage 
at 4
ο
C during one week [28]. 
Absorption of α-Tokopherol in lymph was three times increased by encapsulating the 
compound inside marine lipid based liposomes [29]. 
Encapsulation of β-galactosidaze inside liposomes can reduce the hydrolysis of lactose 
when used in milk prior to consumption. This helps the retention of original milk flavor and the 
digestion of lactose after consumption [30]. 
Slaughter blood haem has been encapsulated into liposomes and used for the fortification 
of bread dough. The addition of liposomal haem increased the fat content of flours. It also had 
positive effect on the stability of the dough. Loaf volume and uniformity of crumb was also 






1.4.3 Pharmaceutical and Medical Research 
 Nisin loaded Nanoliposomes prepared by Mozafari method have been incubated with 
bacteria and microscopy showed the accumulation of liposomes around the bacteria. Also fusion 
of some liposomes with the bacterial membrane after two hours of incubation at 37
ο
C was 
observed. The liposomal formulations were stable for at least 14 months at 4
ο
C and for 12 
months at 25
 ο
C  [32].   
Liposomes prepared with and without polyethylene glycol (PEG) have been used to 
encapsulate albendazole, a hydrophobic drug used for the treatment of hydatid cysts. In vitro 
drug release study showed that the PEGylated liposomes released drug over a longer period of 
time than conventional liposomes. The encapsulation efficiency was also higher for PEGylated 
liposomes [33]. 
Cholesterol succinyl chitosan anchored liposomes have been used to encapsulate 
epirubicin, an anticancer drug having wide range of antitumor activity. In vitro study showed 
more sustained release of drug in both phosphate buffer solution (pH 7.4) and 1% (vol/vol) fetal 
bovine serum compared to plain liposomes. The stability was also higher compared to plain 
liposomes [34].       
The basic fibroblast growth factor (bFgF) has a very short half-life in vivo which limits 
its therapeutic use. Encapsulating it with liposomes can improve the stability and prolong its 
effects in vivo. Studies with rat shows that bFgF encapsulated with liposomes had better effect 




Liposomes encapsulating amikacin sulphate (AMK) have been used to prepare dry 
powder inhaler formulations. Encapsulating the drug inside liposomes prolonged the release of 
drug at the localized site. This reduced the side effects of the drug and frequency of dosing [36]. 
Liposomal formulations have been prepared encapsulating recombinant human insulin 
along with sodium glycocholate for oral insulin delivery. Sodium glycocholate acts as an enzyme 
inhibitor and permeation enhancer. In vitro study of the formulation showed protection of insulin 
against enzymatic degradation by trypsin, pepsin and α-chymotrypsin [37].    
Boron neutron capture therapy is a method for the treatment of cancer which requires the 
selective accumulation of boron in tumor tissue. Transferrin conjugated polyethylene glycol 
liposomes have been used to encapsulate drugs containing boron. In vivo studies with rat showed 
enhanced and prolonged accumulation of boron compound into the solid tumor tissue. The long 
term survival rate was higher for the transferrin polyethylene glycol (PEG) liposomal 
formulation compare to PEG liposomes, plain liposomes and free drug [38].       
Paclitaxel is an approved drug for the treatment of ovarian and breast cancer. 
Conventional commercial formulation is associated with hypersensitivity reactions. Liposomal 
formulation have been made and tested with mice which showed well tolerance and efficient 
treatment of cancer cells [39]. 
Liposome surface coated with polymer having a hydrophobic moiety have been used to 
encapsulate doxorubicin, an anticancer drug. Studies with rat showed targeting efficiency of 




Liposomal formulation containing tamoxifen citrate has been prepared for the sustained 
release of the drug. In vitro studies showed the 50% release of drug within three hours and 95% 
within thirty hours. Liposomes stored at 2-8
ο
C were most stable and only 4% of drug was lost 
over the storage period of five weeks [41]. 
Octadecyl quaternized carboxymethyl chitosan can be used as a liposomal ingredient. 
These liposomes have increased physical and thermal stability, higher solubility in water and 
increased drug encapsulation efficiency. These polymer modified liposomes have been used to 
encapsulate vincristine. The liposomal formulation was stable in aqueous solution and showed 
slow and steady release of drug over two weeks [42].    
Charged and neutral liposomes have been used to encapsulate four types of 
aminoglycosides. Cationic liposomes showed highest entrapment of aminoglycosides.  Studies 
showed intracellular killing of Staphylococcus aureus by canine monocytes was increased when 
liposomes containing aminoglycosides were added to the cultures. The liposomal formulation 
was not toxic to the canine monocytes. The phagocytic ability was not decreased by the 
liposomal formulation [43].  
pH sensitive fusogenic Liposomes modified with succinylated polyglycidol encapsulating 
anti BCG monoclonal antibodies have been used to target tumor cells. In vitro studies with 
mouse colon carcinoma 26 cells showed liposomes attached to the cells and endocytosis 
occurred at 37
ο
C. Endocytosis phenomena occurred in under acidic conditions.  Mouse colon 
carcinoma 26 cells share a common antigen with BCG.  The liposomes recognized the target 
cells and transferred their content into the cytoplasm by fusion with cell membrane and 




Liposomes have been used to make a laser triggered drug delivery carrier system. 
Liposomes encapsulating 6-carboxyfluorescein and dextran-magnetite have been used for this 
purpose. Significant amount of carboxyfluorescein was released in response to a nanosecond 
laser pulse. The probable reason is the increase of liposomal temperature due to laser exposure of 
magnetic materials [45].  
Temperature sensitive drug delivery system has been made by modifying liposomes 
surface with a temperature sensitive polymer. Purpose was to increase the degree of drug release 
from liposomes at the hyper thermic temperature. Calcein was used as a model drug. The release 
behavior of Calcein was a function of both temperature and time. The temperature sensitive 
polymer used was N-isopropyl acrylamide [46]. 
Liposomes have also been used to make an ultraviolet ray induced drug delivery carrier 
system. Photoactive destabilization agent was suprofen. Calcein was used as a model drug. 
Release of Calcein upon exposure to ultraviolet ray was higher for suprofen containing 
liposomes than that of plain liposomes. Linear relationship was found between ultraviolet 
exposure and amount of Calcein released [47].       
Liposomes are also used as gene delivery vector. Cationic liposomes are usually 
employed for this purpose. Incorporating magnetic particles in the liposomes can make them as a 
magnetic carrier system. Magnetic field is used for the accumulation of liposomes in the target 
tissue. Transfection efficiency was higher for magnetic liposomes compared to plain cationic 





2. MATERIALS AND METHODS 
2.1 Preparation of Liposomes 
There are several methods for the preparation of liposomes in small and large scale which 
have their own advantages and disadvantages [1-3]. Heating Method developed by Mozafari et al 
can produce sterile, non-toxic liposomes without use of any organic solvent [18]. The method 
requires the hydration of constituting phospholipids followed by heating in the presence of 
glycerol above the phase transition temperature of the phospholipids [18-20]. Mozafari reported 
that in the presence of cholesterol liposomes were prepared at 120
ο
C and without cholesterol 
they can be prepared at 60-70
ο
C which is greater than the phase transition temperature of most 
phospholipids [18]. In this study Liposomes were prepared in Heating Method without the use of 
any cholesterol and the heating was done at about 100
ο
C . Four different combinations of 
phospholipids were used to prepare liposomes. The phospholipids used to prepare liposomes are 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (16:0 PC); 1,2-dipalmitoyl-sn-glycero-3-phospho-
(1'-rac-glycerol) (16:0 PG); 1,2-distearoyl-sn-glycero-3-phosphocholine (18:0 PC); 1,2-
distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (18:0 PG). All the phospholipids 
were bought from Avanti Polar Lipids Inc. and stored in the freezer. In all four combinations two 
types of phospholipids were used. First the constituent phospholipids were measured in a 
measuring scale (Scientech) and taken in a small vial. Before opening the lid of the 
phospholipids bottle it was kept in open air for some time so that the lipid temperature becomes 
almost equal to the air temperature. Otherwise vapor can condense inside the phospholipid 
bottles and that will degrade the lipids in the long run. In all formulations the lipids were used in 
1:1 molar ratio. Then 1mg of Biotin PC (1-oleoyl-2-[12-biotinyl(aminododecanoyl)]-sn-glycero-




was used to attach the liposomes having biotinylated lipid on a streptavidin coated glass slide. 
Then PBS (1x) was added to the vial to make the final concentration of lipids about 2.5μmol/ml. 
Then the lead of the vial was closed. After that the vial was hold on a vortex generator (Scientific 
Industries Inc.) for 2/3 minutes for the mixing of the phospholipids with the PBS. Then the vial 
was kept at room temperatures for one hour. This was done so that the hydration of 
phospholipids can take place. In the meantime water was taken on a Pyrex beaker (250 mL) and 
the beaker was placed on a hot plate stirrer to make boiling water. Then the vial was put on the 
boiling water beaker. It was kept at boiling water beaker for another one hour. After that the 
heating was stopped and the vial was taken out of the beaker. The lipid suspension in the vial 
was taken on a glass syringe (250 μL). The syringe was part of the liposome extruder set (Avanti 
Polar Lipids Inc.) and it was completely air tight. The suspension was then extruded through 
polycarbonate membrane of 100 nm/1 μm pore diameter   to prepare liposomes. The lipid 
suspension was extruded through the filter fifteen times. Although it was mentioned in the 
manual that eleven times pass is enough to get a homogeneous size distribution. Initially 
liposomes were prepared and characterized using filters of 100nm diameter.  Later all the 
experiments were done using liposomes prepared by extrusion through 1μm nominal pore 
diameter. Liposomes prepared in the size of 100 nm can be characterized by electron microscopy 
but hard to see and analyze by confocal microscopy. Larger liposomes prepared by extruding 
through polycarbonate filters of 1μm pore diameter were studied using Confocal Laser Scanning 








Electron Microscopy is often used to determine the size and shape of liposomes [1]. 
Scanning Electron Microscopy (SEM) has been previously used to characterize liposomes [49]. 
Transmission Electron Microscopy (TEM) was also used to visualize liposomes [50]. Cryo-TEM 
micrograph and Freeze fracture electron micrograph are other two methods which can be used 
for the characterization of liposomes [51, 52]. In this study SEM and TEM were done to 
characterize the liposomes of 100 nm size. Laser Scanning Confocal Microscopy and 
Transmission Light Microscopy were used to study liposomes prepared by extrusion through 1 
μm nominal pore diameter.  All the Electron Microscopy was done in the Socolofsky 
Microscopy Center under the department of Biological Science. The model of Scanning Electron 
Microscope was JSM-6610, JSM-6610LV. The model of the Transmission Electron Microscope 
was JEOL 100CX.The liposomes were homogeneous in size and almost circular in shape. SEM 
was done first for one sample without extrusion through the polycarbonate membrane and the 
liposomes observed were not homogeneous. Then TEM was done for another sample which was 
extruded through polycarbonate membrane of 100nm. The Liposomes observed were almost of 
circular shape and size distribution was homogeneous. Later the liposomes were made by 
extrusion through polycarbonate membrane of 1 μm nominal pore diameter. These liposomes 
were studied using Laser Scanning Confocal Microscopy and Transmission Light Microscopy.  
The microscopy was done using Leica TCS SP2 Confocal Laser Scanning Microscope .The 1 μm 
liposomes were easily visible under light microscopy and the optical resolution of the 
microscope was good enough to distinguish liposomes separately. Light microscopy images were 




























2.3 Attaching Liposomes on Glass Slides 
Cells attach to glass surfaces while cultured and can be studied easily under microscope. 
On the other hand it requires special technique to attach liposomes on glass surface. Researchers 
have tried for years to attach liposomes on solid surfaces which have various applications. Egg 
Phosphatidylcholine liposomes have been immobilized successfully on chemically modified 
hydrophobized Sephacryl gel. The liposomes were was also detachable from the gel [53]. 
Liposomes having biotin group were successfully attached to avidin gels by mixing. The 
liposomes remained stable after storage and chromatography [54]. Liposomes having PEG-
triphenylphosphine have been attached to azide modified glass slide by Staudinger ligation. The 
immobilized liposomes remained intact [55]. Microwells etched on a silicon substrate array and 
functionalized with aminosilane-biotin-neutravidin were used to attach liposomes having 
biotinylated lipids. The liposomes remained stable and intact [56]. Gold surface coated with 
avidin have been used to attach liposomes having biotinylated lipids. Higher biotin concentration 
showed greater attachment and at biotin concentration higher than 30mol% the rupture of vesicle 
was observed forming planer lipid bilayers [57]. Avidin Biotin binding is a popular and very 
effective method to attach liposomes on solid surfaces. Usually the solid surface is coated with 
avidin and liposomes are made with biotin functionalized phospholipids. Biotin-Streptavidin 
binding have been used for this purpose [58-61]. Biotin-Neutravidin binding have also been used 
[62, 63]. In this study streptavidin coated glass slide was used to bind liposomes having 
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Fig 2.4 Apparatus: A is extruder set with heating block. B is air tight syringe. C is extruder set 
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2.4 Nanoparticle Uptake Experiments 
Liposomes were prepared using four different combinations of phospholipids. For all set 
of liposomes experiments were done for four different time of incubation and two different types 
of nanoparticles.  The times of incubation were thirty minute, one hour, two hours and four 
hours.  
 
Silver and gold Nanoparticles were used for the experiments. Nanoparticles were 
collected from Dr. Daniel Hayes from the department of Biological and Agricultural 
Engineering. Silver Nanoparticles were collected in powder form. Fist 5mg of nanoparticles were 
measured in a measuring scale and taken on a 10ml test tube. Then 5ml distilled water was 
added. At this point the concentration of the nanoparticles was 1mg/ml. Then the suspension was 
divided into two parts. One part was kept as it was and the other part was diluted adding more 
water and the concentration was made 0.5mg/ml. The same procedure was done for the second 
sample and the third sample had a concentration of 0.25mg/ml. The third sample was used for all 
the experiments. The Gold Nanoparticles were collected as solution in water and the 
concentration was 9.53 +/- 0.92 mg/L. The average size of the nanoparticles was 60-80 nm. 
 
For the experiments of thirty minute incubation the procedures are as follows. First forty 
μL of liposomes were measured in a measuring pipette and poured on a streptavidin coated glass 
slide. It was kept in open air for thirty minutes. Then ten μL of nanoparticle suspension was 
added to the liposomes. Then the slide with liposomes and nanoparticles was kept in open air for 




nanoparticle and unattached liposomes. Later the slide was watched under microscope to 
determine the uptake of nanoparticles by the liposomes. 
 
For one hour incubation time first forty μL liposomes was poured on a streptavidin 
coated glass slide and then ten μL nanoparticle suspension was added on top of the liposomes. 
Then the slide was kept at open air for one hour. The slides were then gently washed with water. 
After that the slides were studied under microscope. 
 
For two hour incubation first forty μL Liposomes and ten μL Nanoparticles suspension 
were taken on a vial and the lid of the vial was closed. After one hour the mixed solution was 
transferred from the vial on a streptavidin coated glass slide by pipette. Then the slide was kept 
on open air at room temperature for one hour. Then the slide was gently washed with water. It 
was later examined under microscope. 
 
For four hour incubation first forty μL Liposomes and ten μL Nanoparticles suspension 
were taken on a vial and the lid was closed. After three hours the mixed solution was transferred 
on a streptavidin coated glass slide from the vial by pipette. Then the slide was kept on open air 
for one hour. Then the slide was gently washed with water. Later the slide was examined under 
microscope to determine the amount of nanoparticle uptake. 
By doing the above procedure all the samples were exposed to air for same time period of 
time (One hour). At the first stage of experiments samples dried due to evaporation which were 







Nanoparticles made from noble metals can be used for imaging purposes using their 
property of reflecting/scattering light. Gold Nanoparticles conjugated with mouse monoclonal 
antibody have previously been used in Laser Scanning Confocal Microscopy to image SKBR3 
breast carcinoma cells using reflection/scattering of light by the nanoparticles [64].  Compound 
cellular imaging has been done using the scattered light of gold nanoparticles and fluorescence of 
Propidium Iodide (PI) to image human breast cancer cell line [65]. Scattering of light has also 
been used to detect antisense drug made using silver nanoparticles decorated with thiol-
terminated photolabile DNA oligonucleotides inside cells along with fluorescence microscopy 
[66]. Gold nanoparticle conjugated with anti-epidermal growth factor receptor antibodies have 
been used to image cancer cells using both reflection and transmission of light [67].  
  
In this study we examined the reflection/scattering of light by nanoparticles (Silver/ 
Gold) to detect them inside liposomes. The aim of the experiments was to study the uptake of 
nanoparticles by the liposome. In this study both reflection and transmission modes of imaging 
were used. All the microscopy was done using a Leica TCS SP2 Confocal Laser Scanning 
Microscope. An Argon laser was used for the reflection images. The excitation was at 488 nm 
wavelength. Reflection and transmission images were taken simultaneously. HCX PL APO CS 
40x1.25 and HCX PL APO CS 63x1.25 oil immersion lens were used. The pseudo color scheme 
for transmission images were selected as grey and the pseudo color scheme for the reflection 





In reflection mode a laser light of a defined wavelength is passed through the sample. The 
reflected light is captured and image is formed which can be analyzed by a software. 
 
In Transmission mode light is passed through the sample and some light is transmitted. 
The image is formed from the transmitted light. 
 
2.6 Image Analysis 
All the images were taken in both transmittance and reflectance mode of the Microscope. 
The liposomes are visible in transmittance mode and the Nanoparticles reflect light so they are 
visible on reflectance mode. Liposomes which have absorbed or up taken Nanoparticles will 
reflect some light in reflectance mode. So comparing the images of reflectance and 
Transmittance mode one can determine the number of liposomes showing uptake out of total 
number of Liposomes. The uptake was calculated as a percentage of total number of liposomes. 
Total numbers of Liposomes were calculated from the image taken in transmittance mode and 
the number of liposomes showing Nanoparticle uptake was determined from the reflectance 
mode of the microscopy. Although the resolution of the microscope was not capable of detecting 
a single nanoparticle the images were clear enough to tell whether there was any uptake. Some 




    
A 
(1 liposome showing uptake out of 3) 
 
    
B 
( 2 liposomes showing uptake out of 5)  





     
C 
(4 liposomes showing uptake out of 4) 
 
    
D 
(4 liposomes showing uptake out of 11) 







3. RESULTS AND DISCUSSION 
Results are presented as a percentage of liposomes showing nanoparticle uptake out of 
total number of liposomes. Relative comparison can be made among four different liposomal 
formulations and two different types of nanoparticles used.  
3.1 Silver Nanoparticle Uptake 
Table 3.1 Percent of liposomes showing SNP uptake 
Time (min) 18PC & 18PG 16PC & 16PG 16PC $ 18PG 16PG $ 18PC 
0 0 0 0 0 
30 24.85 53 36 42.4 
60 40 63 46 52 
120 45.45 73 52 61 
240 52.17 92 59 67 
Liposomes prepared from 16PC & 16PG phospholipids showed highest amount of uptake 
and the lowest uptake was observed for 18PC & 18PG. The second highest uptake was for 16PG 
$ 18PC followed by 16PC $ 18PG. Liposomal uptake was not a linear function of time. The rate 




Some images are given below showing the uptake of silver nanoparticles by liposomes 
for different types of phospholipids combinations. Transmission and reflection images are given 
side by side to make comparison. Left side images are in reflection mode and right side images 
are taken in transmittance mode of the microscope.  
     
A: Image after 4 hour incubation (18 PC & 18 PG) 
 
      
B: Image after 4 hour incubation (16 PC & 16 PG) 





       
C: Image after 4 hour incubation (16 PC & 18 PG) 
 
       
D: Image after 4 hour incubation (16 PG & 18 PC) 







Fig 3.2 Silver Nanoparticle Uptake by Liposomes 
The graph shows the uptake of silver nanoparticles by liposomes prepared from four 
different combinations of phospholipids. For all combinations the uptake rate is high at the 
beginning which decreases over time. The combination containing shorter alkyl chain 
phospholipids (16 PC & 16 PG) shows highest amount of uptake and the combination larger 
alkyl chain length phospholipids (18 PC & 18 PG) showed lowest amount of uptake. Other two 



















































3.2 Gold Nanoparticle Uptake 
Table 3.2 Percent of liposomes showing GNP uptake 
Time (min) 18 PC & 18 PG 16 PC $ 16 PG 16PC $ 18PG 16PG $ 18PC 
0 0 0 0 0 
30 21 46.8 30.76 35.7 
60 34.8 56.2 40 45.8 
120 42.85 64.7 47.82 53.6 
240 45 72.2 52.17 62.5 
 
The results show similar pattern as obtained from silver nanoparticles. The percentage of 
liposomes showing uptake was lower than that of silver nanoparticles. Maximum uptake was 
72.2% for 16 PC $ 16 PG and for 18 PC & 18 PG the uptake was 45% after four hours of 
incubation. The other two combinations showed some value in between. 
Similar images were obtained for the liposomal uptake of gold nanoparticles. Some 





       
A: Image after 4 hour incubation (18 PC & 18 PG) 
 
       
B:  Image after 4 hour incubation (16 PC & 16 PG) 






            
C: Image after 4 hour incubation (16 PC & 18 PG) 
 
           
D: Image after 4 hour incubation (16 PG & 18 PC) 







Fig 3.4 Gold Nanoparticle Uptake by Liposomes 
The graph shows the percent of liposomes showing gold nanoparticle uptake for four 
different types of liposomes. The pattern is similar to the uptake by silver nanoparticles. The 
corresponding values of uptake are lower than that of silver nanoparticles. Highest uptake was 
observed for 16 PC & 16 PG liposomes and lowest uptake was observed for 18 PC and 18 PG 








































   
Time (min) 
GNP  Uptake vs Time 
16 PC $ 18PG
16 PG &16PC
18 PC &18 PG




3.3 Comparison between SNP and GNP uptake 
 
A: Nanoparticle uptake for 16PC & 16PG Liposomes 
 
B: Nanoparticle uptake for 18PC & 18PG Liposomes 


















































































            
C:  Nanoparticle uptake for 16PC & 18PG Liposomes 
     
D: Nanoparticle uptake for 18PC & 16PG Liposomes 


















































































The above graphs show the comparison of uptake between silver and gold nanoparticles. 
In all cases the uptake was higher for silver nanoparticles. The difference in uptake value was 
maximum for 16 PC & 16 PG liposomes and minimum for 18 PC & 18 PG liposomes. Second 
highest difference was for 16 PC & 18 PG followed by 16 PG and 18 PC liposomes. The 
concentration of SNP was 0.25 mg/mL which was much higher than the GNP concentration 
(10mg/L).  
Comparing the magnitude of the concentration of nanoparticles it can be said that the 
uptake depends more on phospholipids type than the concentration of nanoparticles. There is 
some obvious relationship between alkyl chain length of the phospholipids and the amount of 
uptake. Liposomes prepared from phospholipids having 16 carbons in alkyl chain length might 
be a good carrier for silver and gold nanoparticles of size 60-80nm. 
Silver and gold nanoparticles have previously been used to make drug delivery carrier 
[64-67]. They can be used as imaging and curing agent at the same time [67]. The results 
obtained in these experiments might be useful for the future development of liposome 
encapsulated silver and gold nanoparticle based drug delivery system.   
3.4 Uncertainty Analysis 
Let, P= Actual proportion of liposomes with nanoparticle uptake 
       p= Proportion of liposomes showing uptake in the sample 
       n= Sample size or number of liposomes studied 




Then the estimated variance of p will be 
      





If ‘N’ is much larger than ‘n’ then estimated variance is   
      
   
 
The estimated standard error ‘S’ is the square root of the estimated variance  
S=√
      
   
 
If p=0.5 
   n=26 
Then S=√
      
   
 
           =0.1 
Table 3.3 Estimated standard error in calculating SNP uptake  
Time (min) 18PC & 18PG 16PC & 16PG 16PC $ 18PG 16PG $ 18PC 
30 0.0415 0.0843 0.0876 0.0873 
60 0.1000 0.1053 0.1438 0.1019 
120 0.1086 0.0772 0.0944 0.1182 




Table 3.4 Estimated standard error in calculating GNP uptake  
Time (min) 18PC & 18PG 16PC & 16PG 16PC $ 18PG 16PG $ 18PC 
30 0.0960 0.0896 0.0922 0.1328 
60 0.1015 0.1281 0.0909 0.1038 
120 0.1106 0.1194 0.1064 0.0959 
240 0.1141 0.1086 0.1065 0.1250 
Although the estimated standard error is a bit high, the actual proportion of liposome 
having uptake will be very close to the measured value because the images were almost similar 
all over the slide.  If the number of liposomes considered for analysis is increased the standard 










4. CONCLUSION AND FUTURE WORK 
The objective of this study was to study the uptake of silver and gold nanoparticles by 
liposomes prepared from different types of phospholipids. Four different combinations of 
phospholipids were used to prepare liposomes. The liposomes were incubated with nanoparticle 
solution for four different incubation periods on a streptavidin coated glass slide. A biotinylated 
lipid was used for all types of liposomes prepared. The high binding affinity between 
streptavidin and biotin was used to attach the liposomes on glass slide. After the incubation 
period the slides were washed to wash off unbound liposomes and nanoparticles. Later confocal 
microscopy was used to measure the uptake of liposomes by the nanoparticles. The uptake was 
not a linear function of time. At the beginning the rate of uptake was higher which then 
decreased over time.  The uptake was substantially affected by the type of liposomes used. The 
maximum uptake was obtained for 16 PC & 16 PG liposomes. Uptake was the minimum for 18 
PC & 18 PG liposomes. Uptake was slightly higher for silver nanoparticles than for gold 
nanoparticles although the concentration was much higher for silver nanoparticles. This suggests 
the uptake is mainly dependent on the phospholipids types used to prepare liposomes. The 
relationship between nanoparticle concentration and uptake is not much strong. An important 
parameter which was not studied is the size of the nanoparticles which might have significant 
impact on the uptake phenomena. Future researchers may look on this side and can find the 
optimal nanoparticle size for uptake. The results found in this study might be useful to make 
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